Anna Hirsch
Anna Katharina Herta Hirsch (born 1982 in Trier) is a German-Luxembourg chemist and professor of medicinal chemistry at Saarland University. Since 2017, she has headed the Department of Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS).[1] Her team focuses on targeted rational drug design to regulate enzymes, transporters, and regulators in bacterial, parasitic and viral pathogens.[1] Career and researchHirsch studied natural sciences at the University of Cambridge and completed a year of study at the Massachusetts Institute of Technology. For her master's thesis, Hirsch conducted research in the team of Steven V. Ley at the University of Cambridge.[2] She completed her doctoral thesis in the research group of François Diederich at ETH Zurich. Here Hirsch worked on structure-based de novo design and on the synthesis of anti-infectives.[3] She then moved as an HFSP postdoc to the group of Jean-Marie Lehn at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg.[2] In 2010, Hirsch accepted a position as assistant professor at the Stratingh Institute for Chemistry at the University of Groningen, where she was appointed professor in 2015.[2] In addition to her work as department head at HIPS, she has been a professor of pharmacy at Saarland University since 2017.[4] Honors and awards
References
External links
|
Portal di Ensiklopedia Dunia